TY - JOUR T1 - Optimal Control of Chlamydia Model with Vaccination JF - medRxiv DO - 10.1101/2020.09.09.20191072 SP - 2020.09.09.20191072 AU - U. B. Odionyenma AU - A. Omame AU - N.O. Ukanwoke AU - I. Nometa Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/09/2020.09.09.20191072.abstract N2 - This paper presents an SVEIRT epidemiological model in the human population with Chlamydia trachomatis. The model incorporated the vaccination class and investigated the role played by some control strategies in the dynamics of the disease (Chlamydia tracomatis). The reproduction number which helps in determining the rate of spread of the disease, was calculated using the method proosed by van den Driessche and Watmough. The local and global stability of the equlibrium points where established, where it was observed that the model is locally asymptotically stable if the reproduction number is less than unity, and globally stable if a certain threshold value is greater than unity or the re-nfection rate is zero. The effect of the re-infection rate on the global stability suggests the exhibition of the phenomenon of backward bifurcation of the model. The backward bifurcation of the system was later studied, and it shows that backward bifurcation will occur if the value of the bifurcation parameter ‘a’ is positive. The optimal control of the model shows the effect of different strategies in the transmission dynamicsof the disease and the cost effectivenes of each control pair. It was observed that the treatment and control effort gives the most cost effective combinations and at the same time the highest rate of disease avertion when compared to other stratagies. Sensitivity analysis of the parameters as shown in model, shows parameters that have high impact on the chosen classes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Federal University of Technology OwerriAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData values and plots are available at demand ER -